ArticleTherapeutic advances in medical oncology2018

Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?

Lorenzo Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.